Eupraxia Pharmaceuticals (EPRX) Retained Earnings (2022 - 2026)
Eupraxia Pharmaceuticals' Retained Earnings came in at -$196.72 million for the quarter ended Jun 30, 2026, compared with -$146.51 million a year earlier.
Analysis
Eupraxia Pharmaceuticals (EPRX) Retained Earnings (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Eupraxia Pharmaceuticals' Retained Earnings was -$169.58 million.
- Going back by year, Retained Earnings was -$131 million in the year ended Dec 31, 2024, -$105.5 million in the year ended Dec 31, 2023 and -$77.28 million in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Retained Earnings in data going back to the quarter ended Dec 31, 2022.
- Business Quant data shows EPRX's Retained Earnings at -$182.23 million (quarter ended Mar 31, 2026), -$169.58 million (quarter ended Dec 31, 2025) and -$152.87 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 2.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 15.69 Bn |
| 10 | Eupraxia Pharmaceuticals | 328.04 Mn | 326.44 Mn | - | -196.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -196.72 Mn |
| Mar 31, 2026 | -182.23 Mn |
| Dec 31, 2025 | -169.58 Mn |
| Sep 30, 2025 | -152.87 Mn |
| Jun 30, 2025 | -146.51 Mn |
| Dec 31, 2024 | -131.00 Mn |
| Sep 30, 2024 | -123.49 Mn |
| Jun 30, 2024 | -117.55 Mn |
| Mar 31, 2024 | -111.54 Mn |
| Dec 31, 2023 | -105.50 Mn |
| Dec 31, 2022 | -77.28 Mn |
API Access
Eupraxia Pharmaceuticals Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=EPRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();